Menopause Hormone Therapy (HRT) in Cambridge, MA

Bioidentical hormones in Cambridge: what it means

"Bioidentical" is a word compounding pharmacies often use in marketing, but what it describes is real: a hormone built like the body's own. Estradiol, the main estrogen the ovaries make before menopause, and micronized progesterone both fit that description. FDA-approved versions of both are sold by prescription at retail pharmacies.

Compounded hormones are a different thing: a pharmacy prepares them for one patient, as a cream, a capsule or a pellet. None of these is FDA-approved, and the FDA has not reviewed them for safety, effectiveness or quality before sale. In the FDA's words, it has no evidence that compounded "bioidentical hormones" are safe and effective. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

38 OB-GYNs in the federal NPI registry give a primary practice address in Cambridge: 32.3 per 100,000 residents, above the US rate of 17.8 and above Massachusetts's 21.9, and more per resident than 71% of the 924 cities VevaMD covers. With about 9,162 women aged 45 to 64 living in Cambridge, that is about 240 for each OB-GYN in the city, before counting any younger patients.

Within 25 miles of Cambridge there are 1,043 OB-GYNs for 3,810,642 residents (27.4 per 100,000), well above the national rate; 802 are in the city or within 10 miles. VevaMD is an online option alongside them: a physician licensed in Massachusetts reviews your intake from Cambridge without an office visit, and an OB-GYN you already see stays your doctor.

You do not choose a "bioidentical" product from a menu: after a private intake, a physician licensed in Massachusetts decides what, if anything, fits, and the form. Pellets are not part of it. Since the pharmacy that fills these prescriptions also compounds, ask whether yours is an FDA-approved product or compounded. Testosterone cream for women and Bi-Est are compounded and not FDA-approved.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society cites blood levels well above the expected range in women using compounded pellets. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11